Suzuki T, Ishioka C, Gamo M, Niitani T, Shimodaira H, Kanbe M, Yamazaki T, Yusa Y, Kanamaru R
Dept. of Clinical Oncology, Tohoku University.
Gan To Kagaku Ryoho. 1994 Feb;21(3):343-50.
Genetic alterations of several oncogenes and tumor suppressor genes are associated with human colorectal carcinogenesis. Especially in mutations, the K-ras, p53, APC and DCC gene frequently occurred, and these gene alterations seem to have important roles in colorectal carcinogenesis. We investigated 28 human colon cancer specimens obtained from surgery and five human colon cancer cell lines by PCR-SSCP assay, PCR-OSH assay, RT-PCR or sequencing method. Forty percent of cancers from surgical specimens had Ki-ras 2 (codon 12/13), p53 (Exon 5-8), APC (MCR) gene mutations, and fifty-seven percent of them had lower expression of DCC gene that of normal matched colon mucosa of the same patient. G to A transition was the most frequent in K-ras mutational spectrum in this case; 25% of patients had both k-ras and p53 gene point mutations. Form the results, we concluded that it in colorectal carcinogenesis for both K-ras and p53 gene point mutations might not necessary occur.
几种癌基因和肿瘤抑制基因的遗传改变与人类结直肠癌发生有关。特别是在突变方面,K-ras、p53、APC和DCC基因频繁出现,并且这些基因改变似乎在结直肠癌发生中起重要作用。我们通过PCR-SSCP分析、PCR-OSH分析、RT-PCR或测序方法,对28例手术获取的人类结肠癌标本和5种人类结肠癌细胞系进行了研究。手术标本中40%的癌症存在Ki-ras 2(密码子12/13)、p53(外显子5-8)、APC(MCR)基因突变,其中57%的癌症DCC基因表达低于同一患者正常匹配的结肠黏膜。在这种情况下,G到A的转换在K-ras突变谱中最为常见;25%的患者同时存在k-ras和p53基因点突变。从结果来看,我们得出结论,在结直肠癌发生过程中,K-ras和p53基因点突变不一定都会发生。